Academic and commercial genetic testing laboratories: Complementary if not complimentary

Personalized Medicine

Volumn 4, Issue 4, 2007, Pages 489-495

  Strom, Charles M ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Academic laboratories; Collaboration; Commercial laboratories; Molecular testing

Indexed keywords

DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CLINICAL GENETICS; COMMERCIAL PHENOMENA; COMPETITION; COOPERATION; CYSTIC FIBROSIS; DIAGNOSTIC PROCEDURE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HEALTH CARE FINANCING; HEALTH ECONOMICS; HEALTH SERVICE; HIGH THROUGHPUT SCREENING; HOSPITAL LABORATORY; HOSTILITY; HUMAN; LABORATORY DIAGNOSIS; MANAGED CARE ORGANIZATION; MEDICAID; MEDICAL PRACTICE; MEDICARE; MUTATIONAL ANALYSIS; POPULATION GENETICS; PRIORITY JOURNAL; PUBLICATION; REIMBURSEMENT; SCREENING TEST; TEACHING HOSPITAL; UNIVERSITY HOSPITAL;

EID: 37349071002     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/17410541.4.4.489     Document Type: Article

References (12)

1. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98(3), 503-517 (1975).
2. Cotton RGH, Auerbach AD, Oetting WS: A call for mutations. Genet. Med. 7, 370 (2005).
3. Federal Register, HR 507 (2002).
4. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson M, Desnick RJ: Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet. Med. 3, 149-154 (2001).
5. American College of Obstetrics and Gynecology and American College of Medical Genetics, Preconception and prenatal carrier screening for Cystic Fibrosis, clinical and laboratory guidelines, 2001; October, American College of Obstetrics and Gynecology publication, 409 12th Street SW, PO Box 96920, Washington, DC, USA.
6. Strom CM, Huang D, Buller A et al.: Cystic fibrosis screening using the College Panel: platform comparison and lessons learned from the first 20,000 samples. Genet. Med. 4, 289-296 (2002).
7. Rohlfs EM, Zhou Z, Sugarman EA et al.: The 1148T allele occurs on multiple haplotypes: a complex allele is associated with cystic fibrosis. Genet. Med. 4, 319-323 (2002).
8. Watson MS, Desnick RJ, Grody W, Mennuti MT, Popovich BW, Richards S: Cystic fibrosis carrier screening: issues in implementation, Genet. Med. 4, 407-409 (2002).
9. Buller A, Olson S, Redman J, Strom CM: Frequency of the cystic fibrosis 3199de16 mutation in individuals heterozygous for 1158T. Genet. Med. 6, 108-109 (2004).
10. Watson MS, Cutting GR, Desnick RJ: Cystic fibrosis population carrier screening: 2004 Revision of the American College of Medical Genetics Mutation Panel. Genet. Med. 6, 387-391 (2004).
11. Hantash FA, Milunsky A et al.: A large deletion in the CFTR gene in CBAVD, Genet. Med. 8, 93-95 (2006).
12. Sun WM, Anderson B, Redman J et al.: CFTR 5T variant has a low penetrance in females that is partially attributable to its haplotype. Genet. Med. 8, 339-345 (2006).